Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $5.81

Definitive Healthcare Corp. (NASDAQ:DH) has earned an average recommendation of “Hold” from the eleven research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $5.81.

DH has been the subject of a number of research reports. Stifel Nicolaus cut their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. JPMorgan Chase & Co. cut Definitive Healthcare from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $7.00 to $5.00 in a research note on Wednesday, July 31st. Barclays dropped their price target on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. BTIG Research initiated coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. Finally, Robert W. Baird decreased their price objective on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th.

Institutional Investors Weigh In On Definitive Healthcare

Hedge funds have recently made changes to their positions in the company. Swiss National Bank boosted its stake in Definitive Healthcare by 2.9% during the first quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after acquiring an additional 2,900 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after purchasing an additional 3,332 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Definitive Healthcare by 10.8% in the 2nd quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after buying an additional 3,874 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Definitive Healthcare by 31.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after buying an additional 5,083 shares in the last quarter. Finally, Glenmede Trust Co. NA raised its stake in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after buying an additional 5,362 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Down 3.8 %

Shares of NASDAQ:DH opened at $4.29 on Friday. The company has a market cap of $495.59 million, a price-to-earnings ratio of -1.38, a PEG ratio of 6.59 and a beta of 1.33. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The firm has a fifty day moving average price of $4.36 and a two-hundred day moving average price of $4.92. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.40.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.